Introduction: Shiho Genetics is convinced that talent is the driving force of innovation and the cornerstone of sustainable and healthy development of enterprises. We are looking for the top talents in the related fields all over the world. People are the center of everything we do. We do our best to create an environment and opportunities for true talents to realize their full potential. As a member of Shiho Genetics, you will get: (1) tailor-made personal career development plan (three routes: technical research, marketing and sales, and administration); (2) international first-class academic and research platform; (3) the opportunity of technical exchanges between North America and the United States; (4) the most competitive salary and incentives in the industry; and (5) the benefit of the majority of patients and the spread of positive energy. As a pioneer in individualized medical diagnosis of cancer and molecular diagnosis of rare diseases, Shiho Genetics started to devote itself to the research of high-throughput panoramic cancer gene sequencing at the end of 2008 by a group of North American Chinese scientists who have made outstanding contributions to the field of biomedicine. The North American headquarter is located in Toronto, Canada, and the Chinese headquarter is located in Nanjing, China, with a bioinformatics division in Stanford, USA. The core team of Shiho Genetics consists of PhDs in Cancer Biology and Bioinformatics as well as senior executives with rich experience in corporate management and capital market. The core team comes from prestigious universities in North America and China, such as Stanford, University of Toronto, Harvard, Columbia, Tsinghua and Peking Universities. Shiho's scientific advisory team consists of a number of top international oncologists, including experts and scholars from Harvard University, Massachusetts Institute of Technology (MIT), University of Toronto, and the Chinese Academy of Sciences (CAS). Seva has partnered with a number of prestigious hospitals in China and abroad for clinical diagnostics and translational medicine research. The North American headquarters of Seva Genetics is located at MaRS Hi-Tech Enterprise Park in Toronto, Canada, in the heart of downtown Toronto, near one of Canada's top teaching hospitals and three major universities. the MaRS philosophy is to be the meeting point for science, technology and young entrepreneurs; a place where people from all walks of life spark ideas and win global recognition for their innovation. Seva Genetics' North American laboratories are located at the Banting & Best Institute, part of the University of Toronto, Canada. The Banting & Best Institute has a long history and was founded by Canadian scientists Frederick Banting and Charles B. Banting, who won the 1923 Nobel Prize in Medicine for their discovery of insulin. It is named after Canadian scientists Frederick Banting and Charles Best, who won the 1923 Nobel Prize in Medicine for their discovery of insulin. Bester. In recent years, the old Banting College has been renovated to become a fertile ground for young entrepreneurs to start their own businesses. Remembering the outstanding qualities and research spirit of the former scientists, Shiho people fulfill our commitment to patients with a rigorous scientific attitude. The U.S. branch is located in Silicon Valley, the center of the world's high-tech industry, and is supported by Stanford University, where the world's top scientific research talents are concentrated. The R&D laboratory of Bioinformatics Platform is located in Stanford University, which develops the core technology independently. Seva's China headquarters is located in Nanjing Biomedical Valley. With over 1500 square meters of first-class laboratories. The company owns a full set of high-throughput sequencing platforms, including Illumina HiSeq 2500, NextSeq500, and MiSeq. We are committed to collaborating with the top medical and research institutions in China to conduct translational medicine research and clinical application of individualized medicine for cancer and rare diseases. Website: www.geneseeq.com E-mail: hr@geneseeq.com Tel: 025-56672586
Legal Representative: Huawu Shao
Establishment Date: 2013-03-29
Registered Capital: 17,110,939,000 RMB
Region: Jiangsu Province
Unified Social Credit Code: 91320191062632740Q
Business Status: In Business
Industry: Wholesale and Retail
Company Type: Limited Liability Company
English Name: Nanjing Shihe Gene Bio-Technology Co. ...,Ltd.
Personnel Size: 100-500 people
Enterprise Address: Room 1702, Building B, Phase I, Sino-Danish Eco-Life Science Industrial Park, No.3-1, Xinjinhu Road, Jiangbei New District, Nanjing
Business Scope: Research and development, technical services, and technology transfer, production and sales of biological reagents (excluding hazardous chemicals); biotechnology, biological and biochemical products, Biomedical engineering research and development and related technical services, technical consulting, technology transfer; software development, computers, software and auxiliary equipment (except computer information system security special products) sales; industrial investment; housing rental; self-supporting and agent for all kinds of commodities and technology import and export business; corporate marketing planning, consulting, conference organization and training. (Projects subject to approval in accordance with the law, subject to the approval of the relevant departments before carrying out business activities)